Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
—1,102.181,096.241,103.051,090.35——
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
—616.24616.24617.68609.10——
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
—1,189.721,194.741,202.791,188.58——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
—1,725.691,730.021,762.991,730.02——
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
—643.62643.13643.17632.59——
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
—829.79832.32845.25832.32——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
—213.40213.40216.07213.40——
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
—3,185.923,160.893,178.723,102.60——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
—908.94912.57934.91912.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
—1,478.961,478.171,482.911,466.65——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
—2,405.362,390.342,402.532,359.18——
YP2:FRA
BioLine RX Ltd - ADR
€1.66
-3.49%
(-0.060) 1D
Apr 23, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for YP2...
Open
€1.66
High
€1.66
Low
€1.66
Mkt. cap
11.75M
Avg. vol.
12.00
Volume
0.00
52-wk high
€3.57
52-wk low
€1.66
No. of employees
22
News stories
From sources across the web
Profile
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
About BioLine RX Ltd - ADR
CEOPhilip A. Serlin
Employees22
Founded2003
Headquarters-
SectorBiotechnology
Websitebiolinerx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
255.00K
304.00K
427.00K
194.00K
Cost of goods sold
34.00K
72.00K
84.00K
40.00K
Cost of revenue
34.00K
72.00K
84.00K
40.00K
Research and development expenses
1.62M
2.33M
1.72M
2.42M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
989.00K
209.00K
831.00K
1.12M
Operating expense
2.61M
2.54M
2.55M
3.54M
Total operating expenses
2.65M
2.61M
2.63M
3.58M
Operating income
-2.39M
-2.30M
-2.21M
-3.39M
Other non operating income
7.64M
-1.85M
1.16M
1.10M
EBT including unusual items
5.13M
-3.94M
-977.00K
-2.24M
EBT excluding unusual items
5.13M
-3.94M
-977.00K
-2.24M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
5.13M
-3.94M
-977.00K
-1.38M
Net profit margin
2,010.59%
-1,296.05%
-228.81%
-713.92%
Earnings per share
-
-
-
-
Interest and investment income
294.00K
490.00K
377.00K
-
Interest expense
-420.00K
-276.00K
-304.00K
-288.00K
Net interest expenses
-126.00K
214.00K
73.00K
-288.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.23M
-2.13M
-2.09M
-3.33M
Gain or loss from assets sale
-
-
-
25.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer